{
  "url": "https://openlegislation.uk/infected-blood-compensation-scheme-regulations-2025/schedule-1",
  "json_url": "https://openlegislation.uk/infected-blood-compensation-scheme-regulations-2025/schedule-1.json",
  "legislation": "uksi/2025/404",
  "legislation_title": "The Infected Blood Compensation Scheme Regulations 2025",
  "legislation_url": "https://openlegislation.uk/infected-blood-compensation-scheme-regulations-2025",
  "path": "schedule/1",
  "kind": "schedule",
  "number": "1",
  "heading": "Infection severity levels for Hepatitis B and Hepatitis C",
  "text": "Infection severity level\nDescription of infection severity level\nLevel 1: Hepatitis C only\nAcute infection, being a transient, self-cleared infection\nLevel 2: Hepatitis B and / or Hepatitis C\nChronic infection characterised by:\n(a)Hepatitis B – infection with confirmed Hepatitis B surface antigen (HBsAg) positivity for longer than 6 months with detectable Hepatitis B virus DNA on a polymerase chain reaction test, if not on antiviral therapy\n(b)Hepatitis C – infection with replicating Hepatitis C virus RNA\nLevel 2B: Hepatitis B and / or Hepatitis C\nAn infection of severity level 2 where the person has received interferon treatment for their Hepatitis B or Hepatitis C infection (or both)\nLevel 3: Hepatitis B and / or Hepatitis C\n(1) Cirrhosis, characterised by serious scarring (serious fibrosis) of the liver caused by long-term liver damage caused by infection\n(2) Treatment of B–cell non-Hodgkin’s lymphoma caused by infection – single round treatment (first line therapy)\n(3) Type 2 or 3 cryoglobulinemia caused by infection accompanied by membranoproliferative glomerulonephritis\nLevel 4: Hepatitis B and / or Hepatitis C\n(1) Decompensated cirrhosis caused by infection, characterised by:\n(a) the presence of hepatic encephalopathy (confusion due to liver damage),\n(b) ascites (accumulation of fluid in the abdomen),\n(c) variceal haemorrhage (bleeding from dilated veins in the gullet or stomach), or\n(d) a Child-Pugh score greater than 7\n(2) Treatment of B-cell non-Hodgkin’s lymphoma caused by infection – multiple round treatment (second line therapy)\n(3) Long-term liver damage caused by infection necessitating liver transplantation\n(4) Presence of liver cancer caused by infection\nLevel 5: Hepatitis B only\nInfection resulting in death from acute liver failure within 12 months of infection or within 12 months of reactivation of the infection",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. 1 Table inserted (24.7.2026) by The Infected Blood Compensation Scheme (Amendment) Regulations 2026 (S.I. 2026/872), regs. 1(2), 3(10)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Word in Sch. 1 inserted (31.12.2025) by The Infected Blood Compensation Scheme (Amendment) Regulations 2025 (S.I. 2025/1358), regs. 1(2), 14(10)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 1 in force at 31.3.2025, see reg. 1(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2025/404/schedule/1",
    "retrieved_at": "2026-10-28T21:18:04.224964+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}